Therorna

This early-stage study tests an experimental injection called TI-0093 in 12 people with HPV-16 positive cancers (like head and neck or cervical cancer) that have returned or spread. The main goals are to check safety, find the best dose, and see how the body responds. It is not a…

This early-phase study tests a new therapy called TI-0032-III for people with severe autoimmune diseases like lupus that haven't responded to other treatments. The therapy uses a special injection to create cancer-fighting cells inside the body that target and destroy faulty immu…